Skip to main content

JPMORGAN CHASE & CO

Position in PGEN — Precigen, Inc.

CIK 19617 NEW YORK, NY

Position in PGEN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,840,996
+$1,461,394 QoQ
Shares Held
849,298
-2.7% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. PGEN ranks #119 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PGEN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,840,996 849,298
2026-03-31 $3,379,602 873,283
2025-12-31 $3,824,359 914,919
2025-09-30 $2,501,698 760,395
2025-06-30 $1,106,576 779,280
2025-03-31 $1,211,830 813,310
2024-12-31 $946,570 845,153
2024-09-30 $840,060 884,275
2024-06-30 $1,704,485 1,078,789
2024-03-31 $1,877,319 1,294,704
2023-12-31 $1,799,988 1,343,276
2023-09-30 $1,908,297 1,343,872
2023-06-30 $1,383,157 1,202,746
2023-03-31 $1,285,242 1,212,494
2022-12-31 $1,786,876 1,176,132
2022-09-30 $2,505,465 1,181,824
2022-06-30 $2,301,342 1,717,421
2022-03-31 $3,701,588 1,754,308
2021-12-31 $7,077,550 1,907,696
2021-09-30 $9,194,511 1,842,588
2021-06-30 $10,964,839 1,681,724
2021-03-31 $8,788,688 1,275,572
2020-12-31 $7,856,354 770,231
2020-09-30 $1,882,461 537,846
2020-06-30 $1,671,778 335,026
2020-03-31 $849,068 249,726